A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114

Clinical trial NCT05200273 · UNKNOWN

Trial details

NCT number: NCT05200273
Sponsor: Akeso
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Malignancy Metastasis

Start date: 2022-03-15
Primary completion: 2023-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.